Cargando…
Profiling of intracellular metabolites produced from galactose and its potential for galactosemia research
BACKGROUND: Clinical outcome of patients with a classical presentation of galactosemia (classical patients) varies substantially, even between patients with the same genotype. With current biomarkers, it is not possible to predict clinical outcome early in life. The aim of this study was to develop...
Autores principales: | van Weeghel, Michel, Welling, Lindsey, Treacy, Eileen P., Wanders, Ronald J. A., Ferdinandusse, Sacha, Bosch, Annet M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109347/ https://www.ncbi.nlm.nih.gov/pubmed/30143026 http://dx.doi.org/10.1186/s13023-018-0888-1 |
Ejemplares similares
-
Determination of the lactose and galactose content of common foods: Relevance to galactosemia
por: Shakerdi, Loai A., et al.
Publicado: (2022) -
Abnormal N‐glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake
por: Treacy, Eileen P., et al.
Publicado: (2021) -
Classic galactosemia: dietary dilemmas
por: Bosch, Annet M.
Publicado: (2010) -
Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers
por: Welsink-Karssies, Mendy M, et al.
Publicado: (2020) -
Fertility preservation in female classic galactosemia patients
por: van Erven, Britt, et al.
Publicado: (2013)